Subscribe To
Molecular Partners to Present at SVB Leerink Global Healthcare Conference
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that its Chief Executive Officer, Patrick Amstutz, Ph.D., will participate in the SVB Leerink Global Healthcare conference (Virtual). Conference […] The post Molecular Partners to Present at SVB Leerink Global Healthcare Conference appe...
Read More
Posted: Feb 10 2023, 06:00
Author Name: forextv
Views: 111785